Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: Juliana McElrath

Mymetics – virosomes based vaccines

Posted on by

Mymetics is developing preventative vaccines using both virosomes as an effective adjuvant and vaccine delivery method, and an innovative antigen design to generate mucosal antibodies.

Mymetics – virosomes based vaccines

Mymetics Continue reading →

Posted in Biotech Companies, Biotech Companies Netherlands, Biotech Companies Switzerland | Tagged adjuvant, antigen, Astellas, Astellas Pharma, Cecil Czerkinsky, ClearPath, ClearPath Vaccines Ltd, Herpes Simplex Virus, HIV-I, Juliana McElrath, malaria, Malegapuru Makgoba, Marc Girard, mucosal, mucosal antibodies, mucosal antibody, Mymetic, Mymetics, Mymetics - virosomes based vaccines, preventative vaccine, preventative vaccines, respiratory syncytial virus, Ronald Kempers, RSV, RSV Corporation, Ruth Ruprecht, Solvay, Solvay Pharma, Solvay Pharmaceuticals, Stanley Plotkin, Sylvain Fleury, Toon Stegmann, vaccine delivery method, virosome, virosome based vaccine, virosome based vaccines, virosomes, virosomes based vaccine, virosomes based vaccines

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress